Press Releases

Strategic Vision – Optimal Value

Investor Presentation

Cronos Group News

Cronos Group Provides Update on Minority Investments

Cronos Group Provides Update on Minority Investments

TORONTO, ON--(Marketwired - April 24, 2017) Cronos Group Inc. (formerly PharmaCan Capital Corp.) (TSX VENTURE: MJN) ("Cronos", or the "Company") is providing an update on its investments in Whistler Medical Marijuana Corporation ("Whistler"), The Hydropothecary...

read more
Cronos Recognized as Top TSX Venture 50 Performer

Cronos Recognized as Top TSX Venture 50 Performer

TORONTO, Feb. 27, 2017 /CNW/ - Cronos Group Inc., formerly PharmaCan Capital Corp., (TSX VENTURE: MJN) ("Cronos Group" or "the Company"), is excited to announce the Company's recent recognition as the top performer in the 2017 TSX Venture 50, an award reserved for the...

read more
PharmaCan Capital Announces $15 Million Bought Deal

PharmaCan Capital Announces $15 Million Bought Deal

TORONTO, ONTARIO--(Marketwired - Feb. 14, 2017) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE:MJN) ("Cronos" or the "Company") is pleased to...

read more

Financial Statements

Unaudited Consolidated Financial reports and Management’s Discussion and Analysis reports for Cronos Group will be posted here quarterly. Please visit SEDAR for a complete listing of corporate filings and archived filings for Cronos Group Inc.

76 Stafford Street, Suite 302

Toronto, Ontario M6J 2S1

Info@TheCronosGroup.com
Careers@TheCronosGroup.com

(416) 504-0004